Literature DB >> 22193924

Design and synthesis of fluorescence-labeled closo-dodecaborate lipid: its liposome formation and in vivo imaging targeting of tumors for boron neutron capture therapy.

Hiroyuki Nakamura1, Noriko Ueda, Hyun Seung Ban, Manabu Ueno, Shoji Tachikawa.   

Abstract

The fluorescence-labeled closo-dodecaborane lipid (FL-SBL) was synthesized from (S)-(+)-1,2-isopropylideneglycerol as a chiral starting material. FL-SBL was readily accumulated into the PEGylated DSPC liposomes prepared from DSPC, CH, and DSPE-PEG-OMe by the post insertion protocol. The boron concentrations and the fluorescent intensities of the FL-SBL-labeled DSPC liposomes increased with the increase of the additive FL-SBL, and the maximum emission wavelength of the liposomes appeared at 531 nm. A preliminary in vivo imaging study of tumor-bearing mice revealed that the FL-SBL-labeled DSPC liposomes were delivered to the tumor tissue but not distributed to hypoxic regions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22193924     DOI: 10.1039/c1ob06500a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

1.  Polymer-Stabilized Elemental Boron Nanoparticles for Boron Neutron Capture Therapy: Initial Irradiation Experiments.

Authors:  Alexander Zaboronok; Polina Khaptakhanova; Sergey Uspenskii; Raman Bekarevich; Ludmila Mechetina; Olga Volkova; Bryan J Mathis; Vladimir Kanygin; Eiichi Ishikawa; Anna Kasatova; Dmitrii Kasatov; Ivan Shchudlo; Tatiana Sycheva; Sergey Taskaev; Akira Matsumura
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

2.  In Vitro and In Vivo Evaluation of Fluorescently Labeled Borocaptate-Containing Liposomes.

Authors:  Vladimir Kanygin; Alexander Zaboronok; Iuliia Taskaeva; Evgenii Zavjalov; Rinat Mukhamadiyarov; Aleksandr Kichigin; Anna Kasatova; Ivan Razumov; Roman Sibirtsev; Bryan J Mathis
Journal:  J Fluoresc       Date:  2020-10-19       Impact factor: 2.217

3.  Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.

Authors:  Tatyana Popova; Maya A Dymova; Ludmila S Koroleva; Olga D Zakharova; Vladimir A Lisitskiy; Valeria I Raskolupova; Tatiana Sycheva; Sergei Taskaev; Vladimir N Silnikov; Tatyana S Godovikova
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

4.  Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism.

Authors:  Takahiro Nomoto; Yukiya Inoue; Ying Yao; Minoru Suzuki; Kaito Kanamori; Hiroyasu Takemoto; Makoto Matsui; Keishiro Tomoda; Nobuhiro Nishiyama
Journal:  Sci Adv       Date:  2020-01-22       Impact factor: 14.136

5.  A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy.

Authors:  Makoto Shirakawa; Alexander Zaboronok; Kei Nakai; Yuhki Sato; Sho Kayaki; Tomonori Sakai; Takao Tsurubuchi; Fumiyo Yoshida; Takashi Nishiyama; Minoru Suzuki; Hisao Tomida; Akira Matsumura
Journal:  Cells       Date:  2021-12-05       Impact factor: 6.600

Review 6.  The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry.

Authors:  Katia Messner; Billy Vuong; Geoffrey K Tranmer
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.